The potential hazard of drug-eluting stent-induced coronary vasospasm causing subacute stent thrombosis: a case report.
BMC Cardiovasc Disord
; 16(1): 236, 2016 11 25.
Article
em En
| MEDLINE
| ID: mdl-27887648
ABSTRACT
BACKGROUND:
Drug-eluting stent (DES) -induced coronary vasospasm is a well known phenomenon after stent implantation; however, the extent of this risk is still unknown. We report a case in which DES-induced severe coronary vasospasm was clinically suspected as a cause of subacute stent thrombosis (ST). CASE PRESENTATION A 67-year-old man came to our hospital due to chest pain with mild exercise. He was diagnosed with effort angina by coronary angiography and underwent DES implantation in the mid-left ascending artery (LAD) after the administration of dual anti-platelet therapy. The procedure was uneventful, but his symptoms changed from effort angina to rest angina after stenting. Five days after the procedure, subacute ST occurred, requiring aspiration thrombectomy and balloon angioplasty. Thereafter, he continued to report early morning chest discomfort. We performed a spasm provocation test to evaluate the coronary vasomotor response; it revealed severe stent-edge spasm in the left main trunk to the LAD, except for the stented lesion, and total occlusion of the left circumflex artery.CONCLUSIONS:
To our knowledge, the present case is the first report describing in-stent thrombosis secondary to stent-edge spasm. This case describes the potential hazard of DES-induced coronary vasospasm. Although there are several overlapping risk factors for ST development, we consider that stent-edge spasm also plays an important role in ST development. Therefore, we should monitor new-onset rest angina after stent implantation and carefully assess DES-induced coronary vasospasm.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Vasoespasmo Coronário
/
Vasos Coronários
/
Stents Farmacológicos
/
Oclusão de Enxerto Vascular
Idioma:
En
Ano de publicação:
2016
Tipo de documento:
Article